457 Results

Patent Trial and Appeal Board invalidates Zytiga's 2027 patent and opens the way for generic competition.- Johnson & Johnson.

 Added 2 days ago

. Johnson & Johnson's prostate cancer therapy Zytiga (abiraterone acetate) faces the prospect of generics this year- 2018-, as a...

Breakthrough Therapy designation to Promacta for use in the treatment of severe aplastic anemia as a first-line therapy.-Novartis.

 Added 16 days ago

Novartis has announced that the FDA has granted Breakthrough Therapy designation to Promacta (eltrombopag) for use in combination with standard...

FDA approves Cabometyx for the expanded indication of patients with advanced renal cell carcinoma .- Exelixis.

 Added 25 days ago

Exelixis, Inc. announced that the FDA has approved Cabometyx (cabozantinib) tablets for the expanded indication of patients with advanced renal...

NICE does not recommend Tecentriq for patients who have already received prior treatment for metastatic urothelial cancer. whose disease has progressed after platinum-based chemotherapy.- Roche.

 Added 27 days ago

In draft guidelines, the National Institute for Health and Care Excellence (NICE) notes that treatment options for patients with metastatic...

National crossword puzzle day

 Added 1 month ago

Test your cruciverbalist credentials with our healthcare themed crossword!

Priority review granted for Opdivo

 Added 1 month ago

FDA accepts sBLA for Opdivo + Yervoy to treat advanced renal cell carcinoma

Combination therapy accepted for renal cell carcinoma

 Added 1 month ago

FDA accepts sBLA for Opdivo + Yervoy combination to treat advanced renal cell carcinoma.

Renal cell carcinoma: statistically significant and clinically meaningful results to be publsihed

 Added 1 month ago

Tecentriq + Avastin meet endpoints in Phase III IMmotion151 study for renal cell carcinoma

Prostate cancer trial is unblinded early

 Added 1 month ago

Phase III trial of Xofigo (radium-223 dichloride (radium-223)) in combination with abiraterone acetate and prednisone/prednisolone in prostate cancer.

Load more